Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06674811 · ClinicalTrials.gov registry record
Biomarkers of Resiliency In Childhood Cancer Surgery
A clinical trial of Sarcoma and Neuroblastoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06674811 is a study of Sarcoma and Neuroblastoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06674811, a study of Sarcoma and Neuroblastoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This observational study is to better understand how children and their families recover after the stress of major surgery for cancer so that investigators can create ways to improve resilience during recovery. The main questions it aims to answer are: 1. Can information obtained from patients and their caregivers wearing smartwatches and answering questionnaires be used to measure how patients are recovering from surgery? 2. Are there specific patterns in patients' circulating proteins and metabolites that are associated with stress after surgery? Participants, including pediatric patients undergoing surgery for cancer and their primary caregiver, will be asked to: * wear a smartwatch * complete questionnaires * allow for extra blood to be drawn for this research study when they are having their regular blood draws for clinical purposes These actions will occur at baseline prior to patients' surgery and then afterwards for up to one year. There are no changes to participants' clinical care or surgical care as a result of the study. Investigators will also collect participants' clinical information and cancer-specific outcomes. Participants will be remunerated for their time.
Conditions Studied
Interventions
- OTHER Blood Draw
- OTHER Wearing Smartwatch
- OTHER Patient Report Outcomes
- OTHER Clinical Data Review
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-16 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06674811
The ClinicalTrials.gov registry entry for NCT06674811 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Sarcoma appearing as the primary indexed condition, and to 4 interventions - of which Blood Draw is the first listed.
NCT06674811 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06674811 about?
NCT06674811 is a clinical study titled "Biomarkers of Resiliency In Childhood Cancer Surgery". This observational study is to better understand how children and their families recover after the stress of major surgery for cancer so that investigators can create ways to improve resilience during recovery. The main questions it aims to answer are: 1. Can information obtained from patients and ...
What is the current status of trial NCT06674811?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-01-16. Estimated completion is 2030-01.
What conditions does trial NCT06674811 study?
This clinical trial studies the following conditions: Sarcoma, Neuroblastoma, Pediatric Cancer, Childhood Soft Tissue Sarcoma, Wilms Tumor and Other Childhood Kidney Tumors.
What interventions are being tested in trial NCT06674811?
The interventions under investigation include: Blood Draw (OTHER), Wearing Smartwatch (OTHER), Patient Report Outcomes (OTHER), Clinical Data Review (OTHER).
Who is sponsoring clinical trial NCT06674811?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06674811 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
RECRUITING
-
Palbociclib and Pembrolizumab in Sarcoma
RECRUITING · Phase 1
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
RECRUITING · Phase 1
-
Enhanced Recovery After Surgery in Extremity Sarcoma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.